Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Northern Dynasty Announces Proposed US$13.5 Million Marketed Offering
-
Health Insurance Innovations (HIIQ) Initial 4Q Medicare Trends 'Seem Solid' - Cantor Fitzgerald
-
Cantor Fitzgerald Assumes Unity Biotechnology Inc (UBX) at Overweight
-
Canopy Growth (WEED:CN) (CGC) PT Raised to Cdn$27 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Fiverr International Ltd. (FVRR) at Neutral
-
Omnicell (OMCL) PT Raised to $95 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades ArQule (ARQL) to Neutral Following Acquisition
-
Cantor Fitzgerald Starts Aravive Inc. (ARAV) at Overweight
-
With New CEO, Odds of Constellation (STZ) Buying the Rest of Canopy Growth (CGC) Increases - Analyst
-
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million
-
Cantor Fitzgerald Starts Gossamer Bio Inc. (GOSS) at Overweight
-
Form D/A CANTOR FITZGERALD, L.
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $30 at Cantor Fitzgerald
-
Omeros (OMER) Prices $50M Upsized Share Offering at $13.10/Sh
-
Omeros Announces Pricing of Upsized Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on ViewRay Inc. (VRAY) After Increasing Offering
-
Aurinia Pharmaceuticals (AUPH) Could Triple After AURORA Data - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Neutral Rating on Canopy Growth (WEED:CN) (CGC)
-
Omeros (OMER) to Offer Common Stock
-
Omeros Announces Proposed Public Offering of Common Stock
-
HealthEquity, Inc (HQY) Merger Synergies Boost 3Q Results - Cantor Fitzgerald
-
UnitedHealth Group (UNH) PT Raised to $315 at Cantor Fitzgerald
-
Proteostasis Therapeutics (PTI) PT Lowered to $8 at Cantor Fitzgerald
-
Arrowhead Pharmaceuticals Inc. (ARWR) Prices 4M Share Offering at $58/Sh
-
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
-
Axsome Therapeutics (AXSM) PT Raised to $55 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Maverix Metals (MMX:CN) (MACIF) to Buy
-
Cantor Fitzgerald Upgrades Maverix Metals Inc. (MMX) to Buy
-
Arrowhead Pharmaceuticals Inc. (ARWR) Announces Proposed 4M Share Common Offering
-
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
-
Amarin (AMRN) Vascepa Checks Another Box with EMA Acceptance - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Ahead of Conference Call
-
Evolent Health (EVH) PT Lowered to $10 at Cantor Fitzgerald
-
Aravive Inc. (ARAV) Prices 3.33M Share Common Offering at $7.50/Sh
-
Aravive Announces Pricing of Public Offering of Common Stock
-
Aravive Inc. (ARAV) Plans Public Offering of Common Stock
-
Aravive Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Insurance Innovations (HIIQ) Following Call
-
PropTech Acquisition Corporation Announces Closing of $172,500,000 Initial Public Offering
-
PropTech Acquisition Corporation Announces Closing of $172,500,000 Initial Public Offering
-
Arrowhead Pharmaceuticals Corp (ARWR) May Be Worth $75-$90 in a Sale - Cantor Fitzgerald
-
Acadia Pharmaceuticals (ACAD) PT Raised to $70 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Agios Pharma (AGIO) at Overweight, Favors Upcomign Catalysts and Potential 2020 Outperformance
-
Cantor Fitzgerald Reiterates Overweight Rating on Aurora Cannabis Inc. (ACB:CN) (ACB)
-
Apellis Pharmaceuticals (APLS) PT Raised to $54 at Cantor Fitzgerald Ahead of PEGASUS Near-Term Data
-
Cantor Fitzgerald Assumes Global Blood Therapeutics (GBT) at Overweight
-
Cantor Fitzgerald Defends Health Insurance Innovations (HIIQ)
-
McEwen Mining Announces Closing of US$50 Million Public Offering
-
McEwen Mining Announces Closing of US$50 Million Public Offering
-
StoneCo Ltd. (STNE) PT Raised to $40 at Cantor Fitzgerald

